1-6 of 6
Krishnansu S. Tewari
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial

Open Access
Jung-Min Lee, Richard G. Moore, Sharad Ghamande, Min S. Park, John P. Diaz, Julia Chapman, James Kendrick, Brian M. Slomovitz, Krishnansu S. Tewari, Elizabeth S. Lowe, Tsveta Milenkova, Sanjeev Kumar, Mike Dymond, Jessica Brown, Joyce F. Liu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (19): 4186–4193.
https://doi.org/10.1158/1078-0432.CCR-21-1733
Published: 03 October 2022
View article titled, Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial
Open the PDF for Cediranib in Combination with Olaparib in Patients without a Germline BRCA1/2 Mutation and with Recurrent Platinum-Resistant Ovarian Cancer: Phase IIb CONCERTO Trial in another window
Includes: Supplementary data
Journal Articles

Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218

Available to Purchase
Angeles Alvarez Secord, Kirsten Bell Burdett, Kouros Owzar, David Tritchler, Alexander B. Sibley, Yingmiao Liu, Mark D. Starr, J. Chris Brady, Heather A. Lankes, Herbert I. Hurwitz, Robert S. Mannel, Krishnansu S. Tewari, David M. O'Malley, Heidi Gray, Jamie N. Bakkum-Gamez, Keiichi Fujiwara, Matthew Boente, Wei Deng, Robert A. Burger, Michael J. Birrer, Andrew B. Nixon
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (6): 1288–1296.
https://doi.org/10.1158/1078-0432.CCR-19-0226
Published: 13 March 2020
View article titled, Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218
Open the PDF for Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218 in another window
Includes: Supplementary data
Journal Articles

Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study

Free
Barbara M. Norquist, Mark F. Brady, Maria I. Harrell, Tom Walsh, Ming K. Lee, Suleyman Gulsuner, Sarah S. Bernards, Silvia Casadei, Robert A. Burger, Krishnansu S. Tewari, Floor Backes, Robert S. Mannel, Gretchen Glaser, Cheryl Bailey, Stephen Rubin, John Soper, Heather A. Lankes, Nilsa C. Ramirez, Mary Claire King, Michael J. Birrer, Elizabeth M. Swisher
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (4): 777–783.
https://doi.org/10.1158/1078-0432.CCR-17-1327
Published: 14 February 2018
View article titled, Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study
Open the PDF for Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study in another window
Includes: Supplementary data
Journal Articles

Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study

Free
Krishnansu S. Tewari, Michael W. Sill, Bradley J. Monk, Richard T. Penson, Harry J. Long, III, Andrés Poveda, Lisa M. Landrum, Mario M. Leitao, Jubilee Brown, Thomas J.A. Reid, Helen E. Michael, David H. Moore
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (24): 5480–5487.
https://doi.org/10.1158/1078-0432.CCR-15-1346
Published: 14 December 2015
View article titled, Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study
Open the PDF for Prospective Validation of Pooled Prognostic Factors in Women with Advanced Cervical Cancer Treated with Chemotherapy with/without Bevacizumab: NRG Oncology/GOG Study in another window
Includes: Supplementary data
Journal Articles

Development of Olaparib for BRCA-Deficient Recurrent Epithelial Ovarian Cancer

Free
Krishnansu S. Tewari, Ramez N. Eskander, Bradley J. Monk
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (17): 3829–3835.
https://doi.org/10.1158/1078-0432.CCR-15-0088
Published: 31 August 2015
View article titled, Development of Olaparib for BRCA-Deficient Recurrent Epithelial Ovarian Cancer
Open the PDF for Development of Olaparib for BRCA-Deficient Recurrent Epithelial Ovarian Cancer in another window
Journal Articles

New Strategies in Advanced Cervical Cancer: From Angiogenesis Blockade to Immunotherapy

Free
Krishnansu S. Tewari, Bradley J. Monk
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (21): 5349–5358.
https://doi.org/10.1158/1078-0432.CCR-14-1099
Published: 30 October 2014
View article titled, New Strategies in Advanced Cervical Cancer: From Angiogenesis Blockade to Immunotherapy
Open the PDF for New Strategies in Advanced Cervical Cancer: From Angiogenesis Blockade to Immunotherapy in another window